Omics · study · 2026
Spinal Muscle Degeneration in Dysferlinopathy Affects Gait and Identifies Cellular and Therapeutic Target
Listed in NCBI GEO
Unlike axial myopathy, which is primarily associated with weakness in the spinal muscles, Limb Girdle Muscular Dystrophy 2B/R2 (LGMD2B/R2; dysferlinopathy) causes loss of limb as well as pelvic and shoulder girdle muscles.
Description
However, spinal pathology is often reported in dysferlinopathy patients. Through a cross-sectional magnetic resonance imaging (MRI) analysis of patients with dysferlinopathy and longitudinal analysis of dysferlinopathic mouse model we uncover early-onset and progressive adipogenic degeneration of spinal muscles as a hallmark of this disease.
This is caused by region-specific spinal muscle degeneration, with the iliocostalis, longissimus, and spinalis muscles being most affected. Notably, longitudinal analysis of mouse showed over five-fold greater adipogenic loss of spinal muscle compared to the limb muscles with spinal muscle degeneration preceded the limb muscles. Spinal muscle loss in mice causes decreased spinal tone causing flattening of the body along its length and onset of gait abnormalities.
Read the rest (2 more)
At cellular level, spinal muscle degeneration follows accumulation of damaged myofibers in the affected muscles, and to subsequent increase in local inflammation and accumulation of fibroadipogenic precursors (FAPs). FAPs isolated from spinal muscles display high levels of spontaneous adipogenesis ex vivo, which is greater than FAPs from limb muscles. To target adipogenic differentiation of spinal FAPs, we performed in vitro drug testing and identified a GSK3 inhibitor and an FDA-approved HDAC inhibitor as potential therapeutics.
These findings reveal a poorly recognized anatomical feature of dysferlinopathy, elucidate its cellular mechanisms, and identify potential therapeutic strategies to address spinal muscle degeneration in dysferlinopathy.
Links
Get the data
- GEO FTP directory ftp.ncbi.nlm.nih.gov/geo/series/GSE333nnn/GSE333908 ↗
download · from NCBI GEO
Where it is published
- GEO accession page ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE333908 ↗
landing page · from NCBI GEO
Documentation and papers
- PRJNA1473202 ncbi.nlm.nih.gov/bioproject/PRJNA1473202 ↗
project · from NCBI GEO
Topics
- Stated by source
- Expression profiling by high throughput sequencing · Mus musculus
- From keywords
- Life Sciences
- Inferred from text
- Disease 75% · Imaging 75% · Longitudinal study 65% · Magnetic resonance imaging 75%
Provenance · 1 source records, 11 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| NCBI GEO | GSE333908 | 13 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[disease].local:disease:disease | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[field].local:field:life-sciences | mapping · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencing | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /gdstype |
| concepts[method].local:method:longitudinal-study | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (65%) |
| concepts[modality].local:modality:imaging | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[modality].local:modality:mri | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[organism].NCBITaxon:10090 | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /taxon |
| description | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /summary |
| publication_date | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| title | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /title |